 |
 |
Alpha-1 Antitrypsin Deficiency also known as Alpha-1, A1AD or AATD is an inherited, genetic condition that is passed on from generation to generation. As the name suggests it is a deficiency of alpha-1 antitrypsin (AAT) in the bloodstream. AAT is an enzyme produced in the liver to help protect the tissues of the body during infections. The low level of AAT in the blood occurs because the AAT is abnormal and cannot be released from the liver at the normal rate. This leads to a build up of abnormal AAT in the liver that can cause liver disease and a decrease of AAT in the blood that can lead to lung disease.
Contains 28 pages full of News and Information including:
Charity Annual Update, Members Stories and much more
COVID-19 INFORMATION FOR ALPHA'S
COVID-19 INFORMATION FOR ALPHA'S
The following is a statement from Professor David Parr, Univsersity Hospitals Coventry & Warwickshire
Infor [ ... ]
Chronic Obstructive Pulmonary Disease (COPD) Day
20th November 2019
COPD is a disease that affects a large number of people in the UK. COPD ha [ ... ]
UK sites now open for new drug trial (Astraeus Study) to explore oral compound for Alpha-1 lung disease
8 clinical trial sites now open across [ ... ]
Alpha-1 UK Support Group would like to congratulate our Trustee, Sandra Nestler-Parr, who today has delivered the keynote opening presentation at Ta [ ... ]
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
